Dorros G, Bates M C, Iyer S, Kumar K, King J F, Palmer L, Dufek C, Mathiak L
William Dorros-Isadore Feuer Interventional Cardiovascular Disease Foundation Ltd., Milwaukee, WI 53215.
Eur Heart J. 1994 Nov;15(11):1456-62. doi: 10.1093/oxfordjournals.eurheartj.a060414.
After placement of a Gianturco-Roubin metallic, coiled coronary stent(s) following balloon angioplasty (PTCA), a pre-discharge (7 day) angiogram determined the patency of the old coronary bypass vein graft(s) (SVG) (> or = 5 years remote from their last surgery, mean age: 8.5 +/- 1.8 years). Metallic, coiled stents were successfully deployed in 95/96 (99%) patients within 100/101 (99%) SVGs. The indications for deployment were threatened [81 patients (84%)] or acute [15 patients (16%)] vein graft closure following PTCA. Intragraft urokinase infusion was performed in 17 patients (17%) [6 patients with baseline occlusions; 11 with abrupt closure post PTCA]. Complications encountered included three (3%) in-hospital deaths (two procedure related) two (2%) Q wave myocardial infarctions, six (6%) non-Q wave myocardial infarctions, and 22 (22%) bleeding problems. These included, not mutually exclusively, 21 (22%) requiring transfusions, six (6%) cases of gastrointestinal bleeding, six (6%) pseudoaneurysms, five (5%) retroperitoneal haemorrhages and two (2%) cerebrovascular accidents. All patients received dipyridamole, aspirin, dextran, and anticoagulation (heparin 10-20,000 U intra-procedurally); a heparin infusion was continued for 5 +/- 1 days, despite warfarin administration which attained a therapeutic prothrombin time (PT) (1.5-2 times control) by 3 +/- 1 days. Out of the 95 successfully treated patients, six with eight stented grafts were ineligible for pre-discharge angiography. Of the six, three died in hospital (four SVGs), one had an intracerebral haemorrhage (one SVG), and two were asymptomatic patients with chronic renal failure (three SVGs).(ABSTRACT TRUNCATED AT 250 WORDS)
在球囊血管成形术(PTCA)后植入Gianturco-Roubin金属螺旋冠状动脉支架后,出院前(7天)血管造影确定了旧的冠状动脉搭桥静脉移植物(SVG)(距离上次手术≥5年,平均年龄:8.5±1.8岁)的通畅情况。在101条SVG中的100条(99%)内,96例患者中的95例(99%)成功植入了金属螺旋支架。植入的指征为PTCA后静脉移植物有闭塞风险[81例患者(84%)]或急性闭塞[15例患者(16%)]。17例患者(17%)进行了移植物内尿激酶输注[6例基线闭塞患者;11例PTCA后突然闭塞患者]。遇到的并发症包括3例(3%)住院死亡(2例与手术相关)、2例(2%)Q波心肌梗死、6例(6%)非Q波心肌梗死和22例(22%)出血问题。这些问题包括但不限于21例(22%)需要输血、6例(6%)胃肠道出血、6例(6%)假性动脉瘤、5例(5%)腹膜后出血和2例(2%)脑血管意外。所有患者均接受双嘧达莫、阿司匹林、右旋糖酐和抗凝治疗(术中给予肝素10 - 20,000 U);尽管给予了华法林,且在3±1天达到了治疗性凝血酶原时间(PT)(对照值的1.5 - 2倍),但肝素输注仍持续5±1天。在95例成功治疗的患者中,6例植入了8条支架移植物的患者不符合出院前血管造影条件。这6例患者中,3例在医院死亡(4条SVG),1例发生脑出血(1条SVG),2例为无症状的慢性肾衰竭患者(3条SVG)。(摘要截短于250字)